More than half of elderly metastatic colorectal cancer patients are receiving three or more treatments, increasing cost and side effects with only one-month gain in median survival, new research concludes.
More than half of elderly metastatic colorectal cancer patients are receiving three or more treatments, increasing cost and side effects with only one-month gain in median survival, new research concludes.